AI-driven MRI analysis improves accuracy in distinguishing Parkinsonian disorders
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Joan Catt
Topical JAK Inhibitor Shows Improvement for PN
ORLANDO, Fla. — The topical Janus tyrosine kinase (JAK) 1/2 inhibitor ruxolitinib improved itching and nodules in patients with prurigo...
